Question 1

What are the potential benefits of participating in this trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Repetitive Transcranial Magnetic Stimulation (rTMS) and P50 Evoked Potential Component clinical trial (NCT01466439). Contact the study team or your healthcare provider for specific answers.

Question 2

How will the rTMS sessions be scheduled and what will they involve?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Repetitive Transcranial Magnetic Stimulation (rTMS) and P50 Evoked Potential Component clinical trial (NCT01466439). Contact the study team or your healthcare provider for specific answers.

Question 3

Are there any risks or side effects I should be aware of?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Repetitive Transcranial Magnetic Stimulation (rTMS) and P50 Evoked Potential Component clinical trial (NCT01466439). Contact the study team or your healthcare provider for specific answers.

Question 4

How will my brain activity be monitored during the study?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Repetitive Transcranial Magnetic Stimulation (rTMS) and P50 Evoked Potential Component clinical trial (NCT01466439). Contact the study team or your healthcare provider for specific answers.

Question 5

What happens if I experience any adverse effects during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Repetitive Transcranial Magnetic Stimulation (rTMS) and P50 Evoked Potential Component clinical trial (NCT01466439). Contact the study team or your healthcare provider for specific answers.

Question 6

How will the results of this study contribute to understanding depression and schizophrenia?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Repetitive Transcranial Magnetic Stimulation (rTMS) and P50 Evoked Potential Component clinical trial (NCT01466439). Contact the study team or your healthcare provider for specific answers.

What this study is about